Skip to main content


Stay informed about what is happening at Eshelman Innovation. Check here for the latest updates and news stories.


Chief Strategy Officer for Eshelman Innovation is recognized as the staff recipient for the 2024 Robert E. Bryan Public Service Award from the Carolina Center for Public Service.

Carolina had the scientific expertise. Eshelman Innovation helped bring READDI to life.

An Innovation Engine Evolves

Eshelman Innovation

Eshelman Innovation begins its second decade with a new look and a blueprint for moving groundbreaking health care therapeutics and digital health ideas to reality. 

Eshelman Innovation, within the UNC Eshelman School of Pharmacy, is set to launch a new health tech platform aimed at serving patients with opioid use disorder (OUD).

As part of a new collaboration, Eshelman Innovation, within the UNC Eshelman School of Pharmacy, will work with Aston University on a three-year project focused on preventing damage caused by swelling of the central nervous system (CNS).

“The Rankin Innovator Acceleration Award underscores the importance of supporting our emerging leaders in health care. We are so thankful to have the support of the Rankin family, who truly understands the importance of translating scientific innovation into products that benefit patients around the world,” said John Bamforth, Executive Director of Eshelman Innovation.

2022 was a great year of growth and advancement of our mission. We raised significant new funding from multiple sources that has extended our runway, and allowed us to imagine an impact across the state and potentially beyond.

Eshelman Innovation partnered with the North Carolina Collaboratory to solicit projects from academic researchers across North Carolina for funding research and development that can advance the discovery and translation of therapeutics for opioid use disorders.

In today’s fast-paced and ever-changing world, design thinking has emerged as a powerful venture building tool to solve complex problems and create innovative solutions. 

A $750,000 grant will help Eshelman Innovation create PowerUp—an initiative to address food insecurity and mental health challenges faced by Black North Carolinians. Eshelman Innovation, alongside the Historically Black Colleges and Universities Founders Initiative (HBCUFI), will help source ideas from N.C. A&T and try to refine them into digital for-profit ventures.

Eshelman Innovation is partnering with the Historically Black Colleges and Universities Founders Initiative (HBCUFI) to create PowerUp, a program that will identify and support innovators as they try to solve health equity challenges in underrepresented communities across North Carolina. 

Eshelman Innovation launched the Eshelman Innovation Venture Studio to partner with the University of North Carolina at Chapel Hill in exploring how digital health innovation can improve health care. 

Three-time Eshelman Innovation grant recipient, Katelyn Arnold was recently included in the Forbes 30 Under 30 Science List for 2023.

Eshelman Innovation Venture Studio is a partnership between UNC-Chapel Hill, Eshelman Innovation, UNC Health and industry partner High Alpha Innovation, a leading venture builder headquartered in Indianapolis that partners with large corporations and universities.

The University of North Carolina at Chapel Hill, through Eshelman Innovation, announced a collaboration with Amazon Web Services (AWS) to build an environment for startup creation that uses cloud technology to translate UNC-Chapel Hill digital health research expertise into commercialized solutions.

Carolina leaders from Eshelman Innovation, UNC Health, UNC Research and Innovate Carolina pilot a partnership with High Alpha Innovation aiming to create digital health startups better positioned for success.

The Eshelman Innovation Rankin Innovator Acceleration Award, supported by Lawson and Gisele Rankin, is given annually to provide students and Post Docs with funding to pursue entrepreneurial training opportunities.

READDI has just received a big boost in accomplishing its mission of putting five antiviral drugs “on the shelf” ahead of future pandemics. The National Institutes of Health (NIH) announced Wednesday that READDI will receive an award of $65 million over the next three years to establish the Initiative as an Antiviral Drug Discovery (AViDD) Center for Pathogens of Pandemic Concern.

In 2012, a revolutionary new way to edit genes was unveiled to the world—CRISPR. Since then, the technology has been named as a “Breakthrough of the Year” by Science and has expanded to be applied to targeted epigenome editing. Now, this exciting technology is coming to UNC-Chapel Hill.

We value your privacy.

This website collects cookies to deliver a better user experience. By clicking “Accept”, you consent to our use of cookies.